| Year |
Citation |
Score |
| 2023 |
Avallone M, Pardo J, Mergiya TF, Rájová J, Räsänen A, Davidsson M, Åkerblom M, Quintino L, Kumar D, Bramham CR, Björklund T. Visualizing Arc protein dynamics and localization in the mammalian brain using AAV-mediated gene labeling. Frontiers in Molecular Neuroscience. 16: 1140785. PMID 37415832 DOI: 10.3389/fnmol.2023.1140785 |
0.653 |
|
| 2023 |
Rájová J, Davidsson M, Avallone M, Hartnor M, Aldrin-Kirk P, Cardoso T, Nolbrant S, Mollbrink A, Storm P, Heuer A, Parmar M, Björklund T. Deconvolution of spatial sequencing provides accurate characterization of hESC-derived DA transplants . Molecular Therapy. Methods & Clinical Development. 29: 381-394. PMID 37251982 DOI: 10.1016/j.omtm.2023.04.008 |
0.755 |
|
| 2021 |
Aldrin-Kirk P, Åkerblom M, Cardoso T, Nolbrant S, Adler AF, Liu X, Heuer A, Davidsson M, Parmar M, Björklund T. A novel two-factor monosynaptic TRIO tracing method for assessment of circuit integration of hESC-derived dopamine transplants. Stem Cell Reports. PMID 34971563 DOI: 10.1016/j.stemcr.2021.11.014 |
0.765 |
|
| 2021 |
Björklund T, Davidsson M. Next-Generation Gene Therapy for Parkinson's Disease Using Engineered Viral Vectors. Journal of Parkinson's Disease. PMID 34366370 DOI: 10.3233/JPD-212674 |
0.649 |
|
| 2021 |
Parmar M, Björklund A, Björklund T. In vivo conversion of dopamine neurons in mouse models of Parkinson's disease - a future approach for regenerative therapy? Current Opinion in Genetics & Development. 70: 76-82. PMID 34175529 DOI: 10.1016/j.gde.2021.06.002 |
0.348 |
|
| 2020 |
Negrini M, Wang G, Heuer A, Björklund T, Davidsson M. AAV Production Everywhere: A Simple, Fast, and Reliable Protocol for In-house AAV Vector Production Based on Chloroform Extraction. Current Protocols in Neuroscience. 93: e103. PMID 32865885 DOI: 10.1002/Cpns.103 |
0.638 |
|
| 2019 |
Davidsson M, Wang G, Aldrin-Kirk P, Cardoso T, Nolbrant S, Hartnor M, Mudannayake J, Parmar M, Björklund T. A systematic capsid evolution approach performed in vivo for the design of AAV vectors with tailored properties and tropism. Proceedings of the National Academy of Sciences of the United States of America. PMID 31818949 DOI: 10.1073/Pnas.1910061116 |
0.768 |
|
| 2019 |
Aldrin-Kirk P, Björklund T. Practical Considerations for the Use of DREADD and Other Chemogenetic Receptors to Regulate Neuronal Activity in the Mammalian Brain. Methods in Molecular Biology (Clifton, N.J.). 1937: 59-87. PMID 30706390 DOI: 10.1007/978-1-4939-9065-8_4 |
0.724 |
|
| 2018 |
Tordo J, O'Leary C, Antunes ASLM, Palomar N, Aldrin-Kirk P, Basche M, Bennett A, D'Souza Z, Gleitz H, Godwin A, Holley RJ, Parker H, Liao AY, Rouse P, Youshani AS, et al. A novel adeno-associated virus capsid with enhanced neurotropism corrects a lysosomal transmembrane enzyme deficiency. Brain : a Journal of Neurology. PMID 29788236 DOI: 10.1093/Brain/Awy126 |
0.743 |
|
| 2018 |
Davidsson M, Díaz-Fernández P, Torroba M, Schwich OD, Aldrin-Kirk P, Quintino L, Heuer A, Wang G, Lundberg C, Bjorklund T. Molecular barcoding of viral vectors enables mapping and optimization of mRNA trans-splicing. Rna (New York, N.Y.). PMID 29386333 DOI: 10.1261/Rna.063925.117 |
0.767 |
|
| 2017 |
Aldrin-Kirk P, Heuer A, Ottosson DR, Davidsson M, Mattsson B, Björklund T. Chemogenetic modulation of cholinergic interneurons reveals their regulating role on the direct and indirect output pathways from the striatum. Neurobiology of Disease. PMID 29037828 DOI: 10.1016/J.Nbd.2017.10.010 |
0.74 |
|
| 2016 |
Davidsson M, Diaz-Fernandez P, Schwich OD, Torroba M, Wang G, Björklund T. A novel process of viral vector barcoding and library preparation enables high-diversity library generation and recombination-free paired-end sequencing. Scientific Reports. 6: 37563. PMID 27874090 DOI: 10.1038/Srep37563 |
0.662 |
|
| 2016 |
Aldrin-Kirk P, Heuer A, Wang G, Mattsson B, Lundblad M, Parmar M, Björklund T. DREADD Modulation of Transplanted DA Neurons Reveals a Novel Parkinsonian Dyskinesia Mechanism Mediated by the Serotonin 5-HT6 Receptor. Neuron. PMID 27161524 DOI: 10.1016/J.Neuron.2016.04.017 |
0.752 |
|
| 2016 |
Björklund T. Expression of Multiple Functional RNAs or Proteins from One Viral Vector. Methods in Molecular Biology (Clifton, N.J.). 1382: 41-56. PMID 26611577 DOI: 10.1007/978-1-4939-3271-9_3 |
0.312 |
|
| 2016 |
Davidsson M, Wang G, Aldrin-Kirk P, Hartnor M, Björklund T. 542. Novel Barcode-Based In Vivo Screening Method for Generating De Novo AAV Serotypes for CNS-Directed Gene Therapy Molecular Therapy. 24: S216-S217. DOI: 10.1016/S1525-0016(16)33350-0 |
0.768 |
|
| 2015 |
Davidsson M, Aldrin-Kirk P, Díaz-Fernández P, Quintino L, Lundberg C, Björklund T. 345. A Novel Toolbox for RNA-Editing Based on Massively Parallel Screening Using Barcoded Viral Vectors Molecular Therapy. 23: S137-S138. DOI: 10.1016/S1525-0016(16)33954-5 |
0.749 |
|
| 2015 |
Aldrin-Kirk P, Heuer A, Mattsson B, Wang G, Lundblad M, Parmar M, Björklund T. 18. Novel Approach Using Fetal Dopaminergic Grafts In Situ Transduced with AAV-DREADDs Significantly Increases Behavioral Motor Recovery in a Rat Model of Parkinson's Disease Molecular Therapy. 23: S8-S9. DOI: 10.1016/S1525-0016(16)33622-X |
0.778 |
|
| 2014 |
Holmqvist S, Chutna O, Bousset L, Aldrin-Kirk P, Li W, Björklund T, Wang ZY, Roybon L, Melki R, Li JY. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathologica. 128: 805-20. PMID 25296989 DOI: 10.1007/S00401-014-1343-6 |
0.729 |
|
| 2010 |
Dodiya HB, Bjorklund T, Stansell J, Mandel RJ, Kirik D, Kordower JH. Differential transduction following basal ganglia administration of distinct pseudotyped AAV capsid serotypes in nonhuman primates. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 579-87. PMID 19773746 DOI: 10.1038/Mt.2009.216 |
0.59 |
|
| 2010 |
Soylu R, Hult S, Björklund T, Belgardt BF, Mauer J, Brüning JC, Kirik D, Petersén Å. A24 Hypothalamic expression of mutant huntingtin causes metabolic disturbances in mice Journal of Neurology, Neurosurgery & Psychiatry. 81: A8.1-A8. DOI: 10.1136/Jnnp.2010.222570.24 |
0.667 |
|
| 2009 |
Björklund A, Björklund T, Kirik D. Gene therapy for dopamine replacement in Parkinson's disease. Science Translational Medicine. 1: 2ps2. PMID 20368161 DOI: 10.1126/Scitranslmed.3000350 |
0.558 |
|
| 2008 |
Ulusoy A, Bjorklund T, Hermening S, Kirik D. In vivo gene delivery for development of mammalian models for Parkinson's disease. Experimental Neurology. 209: 89-100. PMID 18028909 DOI: 10.1016/J.Expneurol.2007.09.011 |
0.573 |
|
| 2008 |
Björklund T, Morizane A, Kirik D, Brundin P. Future Cell-and Gene-Based Therapies for Parkinson's Disease Therapeutics of Parkinson's Disease and Other Movement Disorders. 145-156. DOI: 10.1002/9780470713990.ch8 |
0.522 |
|
| 2007 |
Eslamboli A, Romero-Ramos M, Burger C, Bjorklund T, Muzyczka N, Mandel RJ, Baker H, Ridley RM, Kirik D. Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain. Brain : a Journal of Neurology. 130: 799-815. PMID 17303591 DOI: 10.1093/Brain/Awl382 |
0.498 |
|
| Show low-probability matches. |
